Mineralys Therapeutics, Inc. Common Stock MLYS
$15.99
+2.83%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-29 | View → |
| 4 | FORM 4 | 2026-10-20 | View → |
| 4 | FORM 4 | 2026-10-20 | View → |
| 8-K | 8-K | 2026-10-19 | View → |
| 4 | FORM 4 | 2026-10-02 | View → |
| 4 | FORM 4 | 2026-09-24 | View → |
| 4 | FORM 4 | 2026-09-22 | View → |
| 4 | FORM 4 | 2026-09-17 | View → |
| 4 | FORM 4 | 2026-08-25 | View → |
| 4 | FORM 4 | 2026-08-12 | View → |
| 4 | FORM 4 | 2026-08-12 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 4 | FORM 4 | 2026-07-23 | View → |
| 4 | FORM 4 | 2026-07-20 | View → |
| 4 | FORM 4 | 2026-07-15 | View → |
| 4 | FORM 4 | 2026-07-15 | View → |
| 4 | FORM 4 | 2026-07-10 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| 4 | FORM 4 | 2026-06-17 | View → |
| 4 | FORM 4 | 2026-06-17 | View → |
| 4 | FORM 4 | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-03 | View → |
| 424B5 | 424B5 | 2026-06-03 | View → |
| 8-K | 8-K | 2026-06-03 | View → |
| 8-K | 8-K | 2026-05-22 | View → |
| 4 | FORM 4 | 2026-05-19 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 10-Q | 10-Q | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| 4 | FORM 4 | 2026-04-21 | View → |
| 4 | FORM 4 | 2026-04-15 | View → |
| 4 | FORM 4 | 2026-04-15 | View → |
| 4 | FORM 4 | 2026-04-13 | View → |
| DEF 14A | DEF 14A | 2026-04-08 | View → |
| 4 | FORM 4 | 2026-04-02 | View → |
| 4 | FORM 4 | 2026-04-02 | View → |
| 4 | Insider transaction | 2026-03-31 | View → |
| 4 | FORM 4 | 2026-03-17 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $15.99
- Market Cap
- $1.37 billion
- 52-Week Range
- $15.33 – $47.65
- Average Volume
- 1.65 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.